Abstract
Introduction: Monogenic diseases play an important role in critically ill neonates and infants treated in the intensive care unit. This study aimed to determine the diagnostic yield of whole-exome sequencing (WES) for monogenic diseases and identify phenotypes more likely associated with a genetic etiology. Methods: From March 2017 to 2020, a comprehensive diagnostic workup including WES in a single academic center was performed in 61 unrelated, critically ill neonates and infants with an unknown underlying disease within the first year of life. We conducted 59 trio-WES, 1 duo-WES, and 1 single-WES analyses. Symptoms were classified according to the Human Phenotype Ontology. Results: The overall molecular genetic diagnostic rate within our cohort was 46% (28/61) and 50% (15/30) in the subgroup of preterm neonates. Identifying the genetic cause of disease facilitates individualized management in the majority of patients. A positive or negative predictive power of specific clinical features for a genetic diagnosis could not be observed. Conclusion: WES is a powerful noninvasive diagnostic tool in critically ill neonates and infants with a high diagnostic rate. We recommend initiating WES as early as possible due to the impact on management and family counseling. Recommendations regarding the clinical utility of WES in critically ill neonates and infants should not be based on the phenotype alone. Here, we present a clinical workflow for the application of WES for critically ill neonates and infants in an interdisciplinary setting.
References
1.
Widmann
R
, Caduff
R
, Giudici
L
, Zhong
Q
, Vogetseder
A
, Arlettaz
R
, value of postmortem studies in deceased neonatal and pediatric intensive care unit patients
. Virchows Arch
. 2017
;470
(2
):217
–23
. .2.
Kingsmore
SF
, Henderson
A
, Owen
MJ
, Clark
MM
, Hansen
C
, Dimmock
D
, Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing
. NPJ Genom Med
. 2020 Nov 2
;5
:49
. .3.
Petrikin
JE
, Willig
LK
, Smith
LD
, Kingsmore
SF
. Rapid whole genome sequencing and precision neonatology
. Semin Perinatol
. 2015
;39
(8
):623
–31
. .4.
Ferreira
CR
. The burden of rare diseases
. Am J Med Genet A
. 2019
;179
(6
):885
–92
. .5.
Ceyhan-Birsoy
O
, Murry
JB
, Machini
K
, Lebo
MS
, Yu
TW
, Fayer
S
, Interpretation of genomic sequencing results in healthy and ill newborns: results from the babyseq project
. Am J Hum Genet
. 2019
;104
(1
):76
–93
. .6.
Kingsmore
SF
, Cakici
JA
, Clark
MM
, Gaughran
M
, Feddock
M
, Batalov
S
, A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants
. Am J Hum Genet
. 2019
;105
(4
):719
–33
. .7.
Saunders
CJ
, Miller
NA
, Soden
SE
, Dinwiddie
DL
, Noll
A
, Alnadi
NA
, Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units
. Sci Transl Med
. 2012
;4
(154
):154ra135
. .8.
Jacob
J
, Kamitsuka
M
, Clark
RH
, Kelleher
AS
, Spitzer
AR
. Etiologies of NICU deaths
. Pediatrics
. 2015
;135
(1
):e59
–e65
.9.
Bezold
KY
, Karjalainen
MK
, Hallman
M
, Teramo
K
, Muglia
LJ
. The genomics of preterm birth: from animal models to human studies
. Genome Med
. 2013
;5
(4
):34
. .10.
Wadon
M
, Modi
N
, Wong
HS
, Thapar
A
, O'Donovan
MC
. Recent advances in the genetics of preterm birth
. Ann Hum Genet
. 2020
;84
(3
):205
–13
. .11.
French
CE
, Delon
I
, Dolling
H
, Sanchis-Juan
A
, Shamardina
O
, Mégy
K
, Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children
. Intensive Care Med
. 2019
;45
(5
):627
–36
. .12.
Kuehne
B
, Heine
E
, Dafsari
HS
, Irwin
R
, Heller
R
, Bangen
U
, Use of whole exome sequencing in the NICU: case of an extremely low birth weight infant with syndromic features
. Mol Cell Probes
. 2019
;45
:89
–93
. .13.
OMIM Gene Map Statistics. Availabe from: http://www.omim.org/statistics/geneMap.
14.
Willig
LK
, Petrikin
JE
, Smith
LD
, Saunders
CJ
, Thiffault
I
, Miller
NA
, Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings
. Lancet Respir Med
. 2015
;3
:377
–87
. .15.
van Diemen
CC
, Kerstjens-Frederikse
WS
, Bergman
KA
, de Koning
TJ
, Sikkema-Raddatz
B
, van der Velde
JK
, Rapid targeted genomics in critically ill newborns
. Pediatrics
. 2017 Oct
;140
(4
):e20162854
. .16.
Petrikin
JE
, Cakici
JA
, Clark
MM
, Willig
LK
, Sweeney
NM
, Farrow
EG
, The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants
. NPJ Genom Med
. 2018
;3
:6
. .17.
Stark
Z
, Lunke
S
, Brett
GR
, Tan
NB
, Stapleton
R
, Kumble
S
, Melbourne genomics health alliance. meeting the challenges of implementing rapid genomic testing in acute pediatric care
. Genet Med
. 2018 Dec
;20
(12
):1554
–63
.18.
Powis
Z
, Farwell Hagman
KD
, Speare
V
, Cain
T
, Blanco
K
, Mowlavi
LS
, Exome sequencing in neonates: diagnostic rates, characteristics, and time to diagnosis
. Genet Med
. 2018
;20
(11
):1468
–71
. .19.
Meng
L
, Pammi
M
, Saronwala
A
, Magoulas
P
, Ghazi
AR
, Vetrini
F
, Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders effect on medical management
. JAMA Pediatr
. 2017
;171
(12
):e173438
.20.
French
CE
, Delon
I
, Dolling
H
, Sanchis-Juan
A
, Shamardina
O
, Mégy
K
, NIHR bioresource – rare disease; next generation children project, Rowitch DH, Raymond FL. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children
. Intensive Care Med
. 2019 May
;45
(5
):627
–36
.21.
Australian Genomics Health Alliance Acute Care Flagship
; Lunke
S
, Eggers
S
, Wilson
M
, Patel
C
, Barnett
CP
, Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the australian public health care system
. JAMA
. 2020
;323
(24
):2503
–11
. 22.
Smith
HS
, Swint
JM
, Lalani
SR
, Yamal
JM
, de Oliveira Otto
MC
, Castellanos
S
, Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature
. Genet Med
. 2019
;21
(1
):3
–16
. .23.
Köhler
S
, Vasilevsky
NA
, Engelstad
M
, Foster
E
, McMurry
J
, Aymé
S
, The Human Phenotype Ontology in 2017
. Nucleic Acids Res
. 2017
;45
(D1
):D865
–76
. .24.
Mahler
EA
, Johannsen
J
, Tsiakas
K
, Kloth
K
, Lüttgen
S
, Mühlhausen
C
, Exome sequencing in children
. Dtsch Arztebl Int
. 2019
;116
(12
):197
–204
. .25.
Richards
S
, Aziz
N
, Bale
S
, Bick
D
, Das
S
, Gastier-Foster
J
, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology
. Genet Med
. Med2015
;17
:405
–24
. .26.
Siegfried
A
, Cances
C
, Denuelle
M
, Loukh
N
, Tauber
M
, Cavé
H
, Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature
. Am J Med Genet A
. 2017
;173
(4
):1061
–5
. .27.
Milunsky
JM
, Maher
TM
, Zhao
G
, Wang
Z
, Mulliken
JB
, Chitayat
D
, Genotype-phenotype analysis of the branchio-oculo-facial syndrome
. Am J Med Genet A
. 2011
;155A
(1
):22
–32
. .28.
Weckhuysen
S
, Mandelstam
S
, Suls
A
, Audenaert
D
, Deconinck
T
, Claes
LR
, KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy
. Ann Neurol
. 2012
;71
(1
):15
–25
. .29.
Stark
Z
, Lunke
S
, Brett
GR
, Tan
NB
, Stapleton
R
, Kumble
S
, Meeting the challenges of implementing rapid genomic testing in acute pediatric care
. Genet Med
. 2018
;20
:1554
–63
. .30.
Borghesi
A
, Mencarelli
MA
, Memo
L
, Ferrero
GB
, Bartuli
A
, Genuardi
M
, Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant
. Ital J Pediatr
. 2017
;43
(1
):100
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
